Evidence map›Paper›PMID 34572309›Full record

ReviewBiomedicines2021

Pathophysiological Implication of Pattern Recognition Receptors in Fetal Membranes Rupture: RAGE and NLRP Inflammasome.

Helena Choltus, Marilyne Lavergne, Coraline De Sousa Do Outeiro, Karen Coste, Corinne Belville, Loïc Blanchon, Vincent Sapin

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Helena CholtusCNRS, INSERM, GReD, Université Clermont Auvergne, 63000 Clermont-Ferrand, France.
Marilyne LavergneCNRS, INSERM, GReD, Université Clermont Auvergne, 63000 Clermont-Ferrand, France.ORCID 0000-0002-4101-8675
Coraline De Sousa Do OuteiroCNRS, INSERM, GReD, Université Clermont Auvergne, 63000 Clermont-Ferrand, France.
Karen CosteCNRS, INSERM, GReD, Université Clermont Auvergne, 63000 Clermont-Ferrand, France.
Corinne BelvilleCNRS, INSERM, GReD, Université Clermont Auvergne, 63000 Clermont-Ferrand, France.
Loïc BlanchonCNRS, INSERM, GReD, Université Clermont Auvergne, 63000 Clermont-Ferrand, France.
Vincent SapinCNRS, INSERM, GReD, Université Clermont Auvergne, 63000 Clermont-Ferrand, France.
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preterm prelabor ruptures of fetal membranes (pPROM) are a pregnancy complication responsible for 30% of all preterm births. This pathology currently appears more as a consequence of early and uncontrolled process runaway activation, which is usually implicated in the physiologic rupture at term: inflammation. This phenomenon can be septic but also sterile. In this latter case, the inflammation depends on some specific molecules called "alarmins" or "damage-associated molecular patterns" (DAMPs) that are recognized by pattern recognition receptors (PRRs), leading to a microbial-free inflammatory response. Recent data clarify how this activation works and which receptor translates this inflammatory signaling into fetal membranes (FM) to manage a successful rupture after 37 weeks of gestation. In this context, this review focused on two PRRs: the receptor for advanced glycation end-products (RAGE) and the NLRP7 inflammasome.

Indexed as

fetal membranesinflammasomeinflammationNLRPPRRRAGE

Identifiers

PMID34572309
PMCPMC8466405
OpenAlexW3197222685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.